PrivateTechSharesHome › US Pre-IPO › Flatiron Health
Company status · reviewed Oct 2026Flatiron Health has been acquired
Flatiron Health is no longer an independent private company, so this is not a private-secondary situation anymore.
What this means if you hold Flatiron Health equity
Flatiron Health has been part of Roche since 2018, when Roche acquired it for about $1.9 billion — it is not an independent private company. In an acquisition like this, employee shares and vested equity are usually cashed out or converted under the deal terms set by the buyer — not sold in a private secondary. The official deal communications from the company and the acquirer, together with your own equity documents, set out exactly how your grant is treated.
General information only — not financial, tax or legal advice. Check your own equity documents and the official company/deal communications, and take professional advice before acting.
Still hold equity in a company that is private?
That is what PrivateTechShares is for. If your shares, options or RSUs are in a company that has not exited yet, start here — understand what you hold, what it may be worth, and how to prepare.
Value my private equity →Read next
- US private (pre-IPO) companies & how their shares change hands
- EU unicorns & how their shares change hands
- Where to find a buyer for your private shares
- How much are my startup shares worth?
General information only — not financial, tax or legal advice. PrivateTechShares is an education and tools service: it is not a broker or marketplace, does not introduce buyers and sellers, does not hold funds, and does not execute or advise on transactions. Flatiron Health and its logo are the property of their owner.